HomeAPE • FRA
Addex Therapeutics Ltd
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (CHF) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 71.06K | -69.75% |
Operating expense | 521.25K | -32.99% |
Net income | -1.47M | 52.29% |
Net profit margin | -2.07K | -57.73% |
Earnings per share | — | — |
EBITDA | -604.14K | 23.05% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (CHF) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.83M | 73.57% |
Total assets | 9.48M | 184.30% |
Total liabilities | 1.19M | -74.75% |
Total equity | 8.30M | — |
Shares outstanding | 98.35M | — |
Price to book | 0.45 | — |
Return on assets | -15.03% | — |
Return on capital | -16.79% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (CHF) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.47M | 52.29% |
Cash from operations | -598.71K | 72.72% |
Cash from investing | — | — |
Cash from financing | 97.99K | -40.45% |
Net change in cash | -516.25K | 76.93% |
Free cash flow | -269.76K | -143.56% |
Previous close
€0.036
Day range
€0.057 - €0.057
Year range
€0.0030 - €0.069
Market cap
14.39M USD
Avg Volume
1.65K
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
About
Founded
2002
Website
Employees
2
